Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | Piazza C Richard Executive Chairman |
188 | $0 | $0 | 0 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | Baum Douglas R CEO/Director |
188 | $0 | $0 | 0 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | Nelson Christopher M. General Counsel & Executive VP |
91 | $0 | $0 | 0 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | Link Jr. Charles J Director |
41 | $0 | $0 | 0 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | Sax Adriann Director |
5 | $0 | $0 | 0 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-02 10:32 am |
TELIX QSAM INC. | QSAM | King Adam Chief Financial Officer |
11 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-19 Ownership |
2024-02-20 4:51 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner |
8,571 | $5.25 | 115,219 (Direct) |
View |
| 2023-01-15 Ownership |
2024-02-20 4:51 pm |
2023-01-15 2025-01-15 |
QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner |
50,000 | $0 | 115,219 (Direct) |
View |
| 2023-12-19 Ownership |
2024-02-20 4:51 pm |
2023-01-15 2025-01-15 |
QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner |
184,857 | $0 | 115,219 (Direct) |
View |
| 2024-02-06 Conversion(A) |
2024-02-14 4:43 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director |
1,302 | $3 | 376,849 (Direct) |
View |
| 2024-02-06 Conversion(A) |
2024-02-14 4:43 pm |
2021-01-27 N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director |
3,907 | $0 | 376,849 (Direct) |
View |
| 2024-02-06 Conversion(A) |
2024-02-14 4:43 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel |
8,683 | $3 | 182,000 (Direct) |
View |
| 2024-02-06 Conversion(A) |
2024-02-14 4:43 pm |
2021-01-27 N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel |
26,049 | $0 | 182,000 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-13 4:00 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director |
1,302 | $3 | 392,674 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-13 4:00 pm |
2021-01-27 N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director |
3,907 | $0 | 392,674 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-13 4:00 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel |
8,683 | $3 | 197,690 (Direct) |
View |
| 2024-02-06 Conversion |
2024-02-13 4:00 pm |
2021-01-27 N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel |
26,049 | $0 | 197,690 (Direct) |
View |
| 2022-03-03 Option Award |
2023-06-29 06:14 am |
N/A 2032-03-03 |
QSAM Biosciences Inc. | QSAM | King Adam Chief Financial Officer |
35,450 | $0 | 35,450 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-23 4:30 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Sax Adriann Director |
10,455 | $0 | 35,455 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-23 4:30 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Link Jr. Charles J Director |
10,455 | $0 | 108,839 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-23 4:30 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director |
72,276 | $0 | 392,056 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-23 4:30 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman |
72,276 | $0 | 393,487 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-23 4:30 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel |
46,365 | $0 | 193,564 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:13 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO / Director |
50,926 | $0 | 303,271 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:11 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel |
37,037 | $0 | 126,952 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:08 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman |
53,241 | $0 | 305,586 (Direct) |
View |
| 2022-02-21 Option Award |
2022-03-08 4:13 pm |
2022-12-31 2032-02-21 |
QSAM Biosciences Inc. | QSAM | Link Jr. Charles J Director |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:04 pm |
N/A 2032-03-03 |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:02 pm |
N/A 2032-03-03 |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 7:57 pm |
N/A 2032-03-03 |
QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 7:55 pm |
N/A 2032-03-03 |
QSAM Biosciences Inc. | QSAM | Sax Adriann Director |
750,000 | $0 | 750,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-02-17 5:22 pm |
N/A 2032-01-25 |
QSAM Biosciences Inc. | QSAM | Sax Adriann Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-12-06 Ownership |
2022-02-15 1:54 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman |
10,096,775 | $0 | 20,315,575 (Direct) |
View |
| 2021-08-24 Ownership |
2022-02-15 1:54 pm |
N/A 2031-08-23 |
QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman |
127,975 | $0 | 20,315,575 (Direct) |
View |
| 2021-12-06 Ownership |
2022-02-15 06:14 am |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director |
10,096,775 | $0 | 20,323,575 (Direct) |
View |
| 2020-12-30 Ownership |
2022-02-15 06:14 am |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director |
135,975 | $0 | 20,323,575 (Direct) |
View |
| 2021-12-06 Ownership |
2022-02-15 06:11 am |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Link David Charles Director |
2,884,793 | $0 | 5,823,736 (Direct) |
View |
| 2021-08-24 Ownership |
2022-02-15 06:11 am |
N/A 2031-08-23 |
QSAM Biosciences Inc. | QSAM | Link David Charles Director |
55,850 | $0 | 5,823,736 (Direct) |
View |
| 2021-12-06 Ownership |
2022-02-14 9:58 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel and Director Director |
2,884,793 | $0 | 6,307,345 (Direct) |
View |
| 2021-08-24 Ownership |
2022-02-14 9:58 pm |
N/A 2031-08-23 |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel and Director Director |
539,459 | $0 | 6,307,345 (Direct) |
View |
Ownership |
2022-02-14 9:57 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
0 | $0 | 960,456 (Direct) |
View |
| 2021-08-24 Ownership |
2022-02-14 9:57 pm |
N/A 2031-08-23 |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
454,000 | $0 | 960,456 (Direct) |
View |
Ownership |
2021-02-16 4:01 pm |
2018-12-01 2028-12-01 |
QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director |
0 | $0 | 889,958 (Direct) |
View |
| 2020-09-30 Ownership |
2021-02-16 4:01 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director |
705,176 | $0.22 | 889,958 (Direct) |
View |
| 2020-12-17 Ownership |
2021-02-16 4:01 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director |
96,782 | $0.22 | 889,958 (Direct) |
View |
| 2020-01-06 Ownership |
2021-02-16 4:01 pm |
2020-01-06 2030-01-06 |
QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director |
40,000 | $0 | 889,958 (Direct) |
View |
Ownership |
2021-02-16 4:01 pm |
2018-12-01 2028-06-01 |
QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director |
0 | $0 | 108,364 (Direct) |
View |
| 2020-12-17 Ownership |
2021-02-16 4:01 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director |
36,364 | $0.22 | 108,364 (Direct) |
View |
| 2020-01-06 Ownership |
2021-02-16 4:01 pm |
2020-01-06 2030-01-06 |
QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director |
40,000 | $0 | 108,364 (Direct) |
View |
Ownership |
2021-02-16 4:01 pm |
2016-02-25 2026-02-25 |
QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO |
0 | $0 | 1,297,490 (Direct) |
View |
| 2020-09-30 Ownership |
2021-02-16 4:01 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO |
113,636 | $0.22 | 1,297,490 (Direct) |
View |
| 2020-12-17 Ownership |
2021-02-16 4:01 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO |
695,854 | $0.22 | 1,297,490 (Direct) |
View |
Ownership |
2021-02-16 4:00 pm |
2015-11-18 2025-11-18 |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director |
0 | $0 | 1,557,441 (Direct) |
View |
| 2020-10-26 Ownership |
2021-02-16 4:00 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director |
423,609 | $0.22 | 1,557,441 (Direct) |
View |
| 2020-12-30 Ownership |
2021-02-16 4:00 pm |
2020-12-30 N/A |
QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director |
850 | $0 | 1,557,441 (Direct) |
View |
Ownership |
2021-02-16 4:00 pm |
2018-12-01 2028-12-01 |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
0 | $0 | 546,216 (Direct) |
View |
| 2020-09-30 Ownership |
2021-02-16 4:00 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
331,834 | $0.22 | 546,216 (Direct) |
View |
| 2020-12-17 Ownership |
2021-02-16 4:00 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
96,782 | $0.22 | 546,216 (Direct) |
View |
| 2020-01-06 Ownership |
2021-02-16 4:00 pm |
2020-01-06 2030-01-06 |
QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director |
40,000 | $0 | 546,216 (Direct) |
View |
Ownership |
2021-01-27 9:29 pm |
N/A N/A |
QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Strategic Capital Holdings LLC Checkmate Capital Group LLC See Explanation of Responses 10% Owner |
0 | $0 | 18,369,617 (Indirect) |
View |